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An ELISA for sensitive and specific detection of circulating
antigen of Angiostrongylus vasorum in serum samples of
naturally and experimentally infected dogs
Abstract
Canine angiostrongylosis is an emerging cardiopulmonary disease in Europe which can be fatal if left
untreated. We developed a sandwich-ELISA based on a monoclonal antibody (mAb Av 56/1/2) and on
polyclonal rabbit antibodies directed against Angiostrongylus vasorum adult excretory/secretory -
antigen for the detection of circulating serum antigen of A. vasorum. The sensitivity of the test was
95.7% (78.1-99.9, 95% CI) as determined with sera of 23 dogs naturally infected with A. vasorum. The
specificity was 94.0% (83.5-98.7, 95% CI) using 50 dog sera (control group) submitted for reasons other
than parasitic infections. Potential cross-reactions were investigated with sera of a group of totally 61
dogs with proven infections with Dirofilaria immitis (n = 23), Crenosoma vulpis (n = 14), Ancylostoma
caninum (n=4) or Toxocara canis (n = 20). No significant difference was observed concerning the
proportion of positive reactions between the control group and the group with proven helminth
infections other than A. vasorum. In experimentally inoculated dogs with proven worm burdens of A.
vasorum, the proportion of seropositive dogs increased over the first 3 months of infection, starting from
35 days post inoculation (dpi) which was before the onset of larval excretion. Ten weeks post
inoculation, 98.6% of the dogs were seropositive, and circulating antigen persisted in two dogs with
long-term follow-up over 286 and 356 days, respectively. In contrast, in dogs with a single treatment
with imidacloprid/ moxidectin at four or 32 dpi, no circulating antigen was observed, while in dogs
treated at 88-92 dpi, OD values decreased within 13-34 days. The specific detection of circulating A.
vasorum antigen by ELISA represents a valid alternative for reliable diagnosis and for follow-up
investigations after anthelmintic treatment. Moreover, the test can be used for mass screening in large
epidemiological investigations.
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Abstract 15 
Canine angiostrongylosis is an emerging cardiopulmonary disease in Europe which can be fatal if left 16 
untreated. We developed a sandwich-ELISA based on a monoclonal antibody (mAb Av 56/1/2) and on 17 
polyclonal rabbit antibodies directed against Angiostrongylus vasorum adult excretory/secretory – antigen 18 
for the detection of circulating serum antigen of A. vasorum. The sensitivity of the test was 95.7% (78.1-19 
99.9, 95% CI) as determined with sera of 23 dogs naturally infected with A. vasorum. The specificity was 20 
94.0% (83.5-98.7, 95% CI) using 50 dog sera (control group) submitted for reasons other than parasitic 21 
infections. Potential cross-reactions were investigated with sera of a group of totally 61 dogs with proven 22 
infections with Dirofilaria immitis (n = 23), Crenosoma vulpis (n = 14), Ancylostoma caninum (n = 4) or 23 
Toxocara canis (n = 20). No significant difference was observed concerning the proportion of positive 24 
reactions between the control group and the group with proven helminth infections other than A. vasorum. 25 
In experimentally inoculated dogs with proven worm burdens of A. vasorum, the proportion of seropositive 26 
dogs increased over the first 3 months of infection, starting from 35 days post inoculation (dpi) which was 27 
before the onset of larval excretion. Ten weeks post inoculation, 98.6% of the dogs were seropositive, and 28 
circulating antigen persisted in two dogs with long-term follow-up over 286 and 356 days, respectively. In 29 
contrast, in dogs with a single treatment with imidacloprid/moxidectin at four or 32 dpi, no circulating 30 
antigen was observed, while in dogs treated at 88-92 dpi, OD values decreased within 13-34 days. The 31 
specific detection of circulating A. vasorum antigen by ELISA represents a valid alternative for reliable 32 
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diagnosis and for follow-up investigations after anthelmintic treatment. Moreover, the test can be used for 33 
mass screening in large epidemiological investigations.  34 
 35 
Key words: Angiostrongylus vasorum; canine angiostrongylosis; circulating antigen; serology; ELISA; dog.  36 
 37 
1. Introduction 38 
Angiostrongylus vasorum is a metastrongylid nematode living in the pulmonary arteries and the right atrium 39 
and ventricle of wild and domestic carnivores like dogs and wild foxes. Definitive hosts are infected by the 40 
ingestion of snails and slugs containing third-stage larvae (Guilhon, 1963). After a prepatent period of 38-57 41 
days, the adult female worms shed eggs which develop into first-stage larvae (L1) that are coughed to the 42 
pharynx, swallowed and excreted in the faeces (Bolt et al., 1994; Schnyder et al., 2010). Dogs affected by 43 
angiostrongylosis primarily show respiratory signs due to verminous pneumonia but neurological 44 
deficiencies and coagulopathies are also described (Chapman et al., 2004; Koch and Willesen, 2009). If left 45 
untreated, the infection can be fatal (Koch and Willesen, 2009; Staebler et al., 2005). 46 
The current diagnosis of A. vasorum infections is based on the detection of L1 in faecal samples. Simple 47 
faecal smears can be used for  diagnosis in general practice (Humm and Adamantos, 2010) but larval 48 
migration techniques such as the Baermann-Wetzel technique (Eckert et al., 2008) are recommended. Both 49 
methods may allow morphological differentiation from further lung worm larvae such as Crenosoma vulpis 50 
and Filaroides spp. (Eckert et al., 2008; McGarry and Morgan, 2009). However, the sensitivity of these 51 
methods is reduced in cases of low worm burdens and when analysing posted faecal samples that arrive 52 
with delay at the laboratory and therefore containing deformed or dead larvae. Also, dogs with prepatent 53 
infections are not detected.  54 
Therefore, alternative diagnostic tools are needed. An alternative may be represented by the employment 55 
of novel molecular tools such as PCR (Traversa and Guglielmini, 2008). Real-time PCR with blood or 56 
faeces spiked with L1 had low detection limits, but when samples of suspected clinical animals were 57 
compared with single faecal examination performed with the Baermann’s method, in both subsets PCR 58 
negative/Baermann’s positive and PCR positive/Baermann’s negative results were observed (Jefferies et 59 
al., 2009). Furthermore, a ‘sieve-PCR’ method developed to facilitate the processing of larger faecal 60 
volumes was described as a non-invasive tool for wildlife surveillance and for confirmative diagnosis in 61 
dogs or foxes (Al-Sabi et al., 2010). Molecular techniques are particularly recommended for prevalence 62 
studies in intermediate mollusc hosts (Ferdushy et al., 2009). The serologic detection of A. vasorum – 63 
infections in dogs could represent a valid alternative for diagnosis both, in individuals and in population 64 
studies. The detection of specific antibodies against A. vasorum was first described by Guilhon et al. (1971) 65 
and later applied in follow-up studies in experimentally infected dogs (Costa et al., 1996; Cury et al., 1996). 66 
Specific antibody reactions were analysed by Western blot, revealing immunogenic antigens of different 67 
molecular weight in crude extracts of adult female worms (Cury et al., 2002). Later, stage-specific antigens 68 
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were identified using sera of dogs experimentally infected with A. vasorum (De Oliveira Vasconcelos et al., 69 
2008). A sandwich-ELISA using polyclonal antibodies of rabbits immunized with adult worm antigens 70 
illustrated the potential of the detection of circulating antigen in dogs naturally infected with A. vasorum 71 
(Verzberger-Epshtein et al., 2008). The aim of this investigation was to evaluate the diagnostic features 72 
(sensitivity, specificity) of an ELISA for the detection of A. vasorum circulating antigen in experimentally and 73 
naturally infected dogs.  74 
 75 
 76 
2. Materials and Methods 77 
2.1 Angiostrongylus vasorum antigens 78 
Excretory/secretory (E/S) antigen was obtained from living adult parasites isolated by a reverse lung 79 
perfusion technique from foxes and dogs during previous experiments (Schnyder et al., 2010; Webster et 80 
al., 2007). Parasites were thoroughly washed with RPMI 1640 L-glutamine with 200 IU penicillin/ml and 200 81 
μg streptomycin/ml and incubated in the same medium at +37° C and with 5% CO2 in a concentration of 20 82 
worms/30ml. The medium was replaced every day during the first five days and discarded in order to 83 
reduce potential contaminations with host antigens. The viability of the worms was judged by their motility, 84 
and inactive or dead worms were removed before fresh medium was added. Afterwards, the medium was 85 
harvested twice a week and supernatant stored at -20° C after centrifugation (2000 g, 10 minutes) until 86 
further processing. After sterile filtration through a 0,22 μm sieve (Millipore Corporation, Billerica, 87 
Massachusetts, USA), the collected media were concentrated using YM-10 membranes (discs of 10 kDa 88 
NMWL) (Millipore) in a pressurized (3.5 bar) Amicon ultrafiltration unit.  89 
 90 
2.2. Polyclonal antibodies 91 
Female New Zealand White rabbits were subcutaneously immunized with 150 µg of A. vasorum adult E/S-92 
antigen diluted in PBS (phosphate buffered saline) and Freund’s complete adjuvant. A booster was 93 
performed four weeks later with Freund’s incomplete adjuvant, followed by a terminal bleed four weeks 94 
later. Serum was collected and stored at -20° C.  95 
 96 
2.3. Monoclonal antibodies 97 
Monoclonal antibodies (mAb) were produced with a modified protocol (de StGroth and Scheidegger, 1980) 98 
as follows. NMRI (Naval Medical Research Institute) mice (Janvier, Le Genest St. Isle, France) were 99 
subcutaneously immunized with 20 µg of adult A. vasorum E/S antigen in a volume of 50 µl PBS (28.25 µl 100 
antigen and 21.75 µl sterile PBS) mixed with 50 µl Freund’s complete adjuvant. This was repeated twice in 101 
an interval of 3 weeks using the same amount of antigen in Freund’s incomplete adjuvant, followed by 102 
subcutaneous boosters of antigen with PBS for three days directly before decapitation under anaesthesia. 103 
4 
 
Spleen cells of the immunized mice were then removed aseptically, washed and lymphocytes were mixed 104 
with the same amount of AG8 myeloma cells. The mixed cells were washed and incubated for 90 seconds 105 
at 37°C in polyethylene glycol (PEG) which was carefully diluted stepwise with pre-warmed PBS. Fused 106 
myeloma cells were initially cultivated in 96-well plates (Techno Plastic Products, Trasadingen, 107 
Switzerland) at 37° C and 5% CO2 in conditioned Iscoves mod. Dulbecco medium (Sigma, St. Louis, 108 
Missouri USA), with HAT (Sigma), 5% fetal calf serum, 1% L- glutamine (Sigma), 0.5% L-Anyl-L-Glutamine 109 
200mM (Sigma), 2% IL-6 and 0.1% Gentamicin (Sigma). This culture medium was gradually substituted by 110 
non-conditioned medium and later by a culture medium with HT (Sigma) instead of HAT. Finally, the cells 111 
were cultivated in culture medium without any further additives. 112 
Antibody production of the cells was checked by an ELISA using A. vasorum adult E/S antigen. 113 
Supernatants positive in the primary screening were subsequently tested for specificity in ELISA with 114 
Dirofilaria immitis adult E/S antigen (Deplazes et al., 1995). Sera from known naturally infected and from 115 
negative dogs served as controls. Selected clones were subcloned twice to assure that the antibody 116 
production was monoclonal. Clones positive for A. vasorum adult E/S and negative for D. immitis adult E/S 117 
antigens were transferred into cell culture flasks (Techno Plastic Products, Trasadingen, Switzerland), the 118 
supernatant containing the antibodies was collected and stored at -20° C. Supernatants were concentrated 119 
with an Amicon filtration unit and YM-30 membranes (both Millipore). The mAbs were purified on protein G 120 
columns (Protein G Sepharose 4 Fast Flow, GE Healthcare, Buckinghamshire, UK) according to the 121 
manufacturer’s instructions, and dialyzed against PBS with a pleated dialysis tubing (Snake Skin®, Pierce, 122 
Thermo Fisher Scientific, Waltham, MA, USA). Isotypes were determined by a monoclonal antibody 123 
isotyping kit (Ap/PNPP, Pierce). All protein concentrations were assessed by a Bio-Rad protein assay and 124 
with a protein standard of 1.37μg/ml.  125 
 126 
2.4. Sandwich- ELISA 127 
Tests were performed in 96-well microtiter plates (Maxisorp, Nunc Roskilde, Denmark). Optimal 128 
concentrations of monoclonal antibodies, serum dilutions, polyclonal rabbit serum and goat anti - rabbit IgG 129 
(F(ab’)2 fragment) conjugated to alkaline phosphatase (Sigma) were determined by titration experiments. 130 
Plates were coated overnight at 4° C with 2.5 µg/ml of a selected mAb (mAb Av 56/1/2), diluted in 0.1 M 131 
carbonate/bicarbonate buffer (pH 9.6) containing 0.02% NaN3. Plates were washed four times with 132 
physiological NaCl/0.3% Tween-20 (NaCl-T) before saturation for 30 min at 37° C with PBS (pH 7.2) 133 
containing 0.02% NaN3, 0.05% bovine haemoglobin (Fluka) and 0.2% (v/v) Tween-20 (PBS-T). Serum 134 
dilutions (100 µl/well, 1:2 in PBS-T) were incubated for 1 h at +30° C and the plates were subsequently 135 
washed four times with NaCl-T. Afterwards, hyperimmune polyclonal rabbit serum (100 µl/well) was added 136 
in a concentration of 1:500, incubated for 1 h at 30° C, and plates again washed four times with NaCl-T 137 
before adding 100 µl/well goat anti-rabbit IgG conjugated to alkaline phosphatase and diluted in PBS-T 138 
(1:2’500). After the repetition of the incubation and washing steps, 100 µl/well of a 1 mg/ml solution of p-139 
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nitrophenyl phosphate (Sigma) in 0.05 M carbonate/bicarbonate buffer (pH 9.8) containing 1 mM MgCl2 140 
were added. Absorbance values were read at 405 nm (OD405) with a Multiscan RC ELISA reader (Thermo 141 
Labsystems, Helsinki, Finland). A panel of positive (from experimentally inoculated dogs) and negative 142 
control sera (from laboratory dogs, known to be free of A. vasorum) were included in all test runs. In 143 
particular a strong positive serum (serum P) diluted 1:200 was run twice in every plate. The mean OD value 144 
was compared with the values of a reference plate and used for the adjustment between plates applying 145 
the following correction factor: (mean OD value of serum P diluted 1:200 from the reference plate) / (mean 146 
OD value of serum P diluted 1:200 from the test plate).  147 
 148 
2.5. Source of dog sera 149 
The sera used for analytical and comparative investigations were obtained from the following sources: 150 
(a) A total 40 dogs were experimentally inoculated with third stage larvae (L3) harvested from 151 
experimentally infected Biomphalaria snails and regularly (mostly every 1-2 weeks) bled during 152 
previously performed experimental trials. Three dogs were inoculated with 50 and further 3 dogs 153 
with 500 L3, while the remaining dogs received 200 L3 (Schnyder et al., 2009; Schnyder et al., 154 
2010). Twenty-three dogs were subject to anthelmintic treatment: two groups of eight dogs each 155 
were treated with imidacloprid 10 mg/kg body weight (BW)/moxidectin 2.5 mg/kg BW spot-on 156 
(Advocate®, Bayer Animal Health) at 4 or 32 days post inoculation (dpi), respectively, while a third 157 
group (n=5) was treated at 88-92 days dpi. Further two dogs were treated at the same moment with 158 
an experimental compound (Schnyder et al., 2010). The remaining seventeen dogs were left 159 
untreated and the worm burden was determined at necropsy at different time points in all dogs (two 160 
dogs: long term follow-up). The larval excretion was followed up daily starting from 40 dpi by the 161 
Baermann-Wetzel technique (Eckert et al., 2008). Patency in untreated dogs was detected at 47-53 162 
dpi, and larval excretion in dogs treated at 88-92 dpi stopped within 21 days after treatment. 163 
(b) Twenty-three sera were collected from naturally infected dogs presented at the Veterinary Hospital 164 
of the Vetsuisse Faculty of the University of Zurich and from German dogs with clinical symptoms 165 
of respiratory and circulatory disease, bleeding disorder and/or neurological signs (Barutzki and 166 
Schaper, 2009). Infection was confirmed by isolation of L1 in faecal samples using the Baermann-167 
Wetzel technique.  168 
(c)  A further 14 sera from the above mentioned sources were collected from dogs excreting L1 larvae 169 
of Crenosoma vulpis.  170 
(d) Additionally, the following sera diagnosed at the diagnostic unit of the Institute of Parasitology, 171 
University of Zurich, in Zurich, were used for specificity evaluations: 20 sera from dogs 172 
experimentally infected with Toxocara canis eggs and tested positive for egg excretion, 4 from dogs 173 
experimentally infected with Ancylostoma caninum (kindly provided from the Institute of 174 
Parasitology, University of Veterinary Medicine, Hannover), and 23 sera tested positive for the 175 
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presence of Dirofilaria immitis antigen (DiroCHEK®, Synbiotics, San Diego, USA) and/or 176 
microfilariae characterized with the acid phosphatase stain.  177 
(e) A total of 30 randomly chosen samples submitted to the Veterinary Laboratory of the Veterinary 178 
Hospital of the Vetsuisse Faculty of the University of Zurich for various reasons not correlated with 179 
suspected parasitological infections were used for the determination of the cut-off value. The cut-off 180 
was determined by the mean optical density (OD) value adding 3 standard deviations (SD). Further 181 
50 randomly chosen sera were used to calculate the specificity (control group). 182 
 183 
2.7. Statistical analysis 184 
Statistical analysis was performed using Excel 2007 for Windows (Microsoft Corporation, Redmond, USA) 185 
and GraphPad Prism version 4.00 for Windows (GraphPad Software, San Diego California USA, 186 
www.graphpad.com).  187 
 188 
2.8. Animal permissions 189 
The experimental foxes were reared and purchased from a fur farm and housed individually at the LIFE 190 
faculty’s animal experimental facilities under the Danish experimental animal licence no. 2005/561-1060 191 
and treated according to the animal ethics laws of Denmark. Experiments with dogs, mice and rabbits were 192 
conducted according to the Swiss guidelines for animal experimentation and approved by the Cantonal 193 
Veterinary Office of Zurich prior to study start. They were carried out with facility-born animals at the 194 
experimental units of the Vetsuisse Faculty in Zurich (permission numbers 25/2006, 26/2007, 13/2008, 195 
185/2008). 196 
 197 
3. Results 198 
The use of a selected mAb, designated ‘mAb Av 56/1/2’ (IgG1 isotype), and rabbit polyclonal antibodies in 199 
a sandwich-ELISA allowed the detection of circulating A. vasorum antigen. Titration of A. vasorum adult 200 
E/S antigen revealed a detection level of 0.06 µg/ml in an A. vasorum negative dog serum that was diluted 201 
1:1 with PBS-T. 202 
 203 
3.1. Determination of the diagnostic sensitivity and specificity 204 
In 22 out of 23 dogs naturally infected with A. vasorum (diagnosed by Baermann-Wetzel technique), ELISA 205 
values above the diagnostic cut-off were determined (Fig. 1), indicating a sensitivity of 95.7% (95% 206 
Confidence Interval – CI: 78.1-99.9). 207 
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The specificity of the ELISA calculated with 50 control samples submitted for various reasons that were not 208 
correlated with suspected parasitological infections was 94.0 % (95% CI: 83.5-98.7). Cross-reactivity was 209 
tested with a total of 61 samples from dogs with proven parasitic infection and is shown in Fig. 1. One of 14 210 
sera from dogs excreting L1 of C. vulpis showed strong positive reactions. A single serum positive for D. 211 
immitis – antigen had a low positive reaction in the A. vasorum ELISA. No significant difference was found 212 
concerning positive reactions between the control group and dogs with proven other parasitic infections.  213 
 214 
3.2. Circulating A. vasorum serum antigens during experimental A. vasorum infections 215 
In dogs experimentally inoculated with A. vasorum, seropositivity increased over the first 3 months of 216 
infection (Tab. 1). The results of serological follow-ups of 17 dogs confirmed to be infected with A. vasorum 217 
at necropsy and corresponding worm burdens are shown in Fig. 2 and 3. Dogs became positive for A. 218 
vasorum circulating serum antigen starting from 35 dpi and latest at 77 dpi. One dog harbouring a high 219 
worm burden (165) at 55 dpi was seropositive only at 35 dpi, while all samples of the other dogs had 220 
increasing optical densities during the progressive course of infection. During a long-term follow-up of two 221 
dogs, circulating antigen was regularly detected at high levels (Fig. 3). 222 
In contrast, OD values of four out of five infected dogs that were treated with the spot-on solution containing 223 
imidacloprid/moxidectin decreased after the drug administration. No worms could be found in these dogs at 224 
necropsy (Fig. 4). Three out of 5 dogs became negative within 16-34 days after treatment, while the one 225 
dog harbouring still one worm at necropsy remained positive for A. vasorum antigen detection. In sera of 226 
dogs treated at 4 (n=8) or 32 (n=8) dpi, no antigen could be detected by the sandwich-ELISA during the 227 
whole follow-up until 55 dpi.  228 
 229 
4. Discussion 230 
A valid and affordable diagnostic method for the detection of A. vasorum - infected animals before the 231 
appearance of clinical signs could avoid the onset of severe pathological changes in early anthelmintic-232 
treated animals. Diagnosis of infections with this potentially fatal parasite is mainly achieved by larval 233 
detection in faecal samples, and the sensitivity of these methods can be increased by multiple faecal 234 
examinations, as reported from recent prevalence studies (Barutzki and Schaper, 2009; Taubert et al., 235 
2008). However, due to low compliance of animal owners for multiple faecal collections and difficulties to 236 
always guarantee proper storage of faecal samples, alternative methods are needed. 237 
The identification of stage-specific antigens of A. vasorum suggested that they are potential candidates for 238 
future use in diagnostics (De Oliveira Vasconcelos et al., 2008). Verzberger-Epshtein et al. (2008) 239 
developed a sandwich-ELISA for the detection of circulating worm antigen using rabbit polyclonal antiserum 240 
directed against whole adult worm antigen. The test was evaluated with sera from dogs from endemic and 241 
non-endemic regions from Canada showing high specificity and sensitivity. Cross-reactions against several 242 
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helminths were evaluated, and in particular no reactions were found with sera of animals infected with C. 243 
vulpis, a lung worm known to be widely distributed (Conboy, 2004). However, no samples of animals 244 
infected with D. immitis, which, like A. vasorum, is residing in the right heart of definitive hosts as an adult 245 
stage, and known to produce circulating antigens, were investigated.  246 
The present study aimed to develop a reliable diagnostic tool for the serological diagnosis of an A. vasorum 247 
infection in dogs. Our first results using A. vasorum adult E/S antigen for the production of rabbit polyclonal 248 
antibodies resulted in a prototype ELISA with low specificity when sera of dogs infected with D. immitis 249 
were tested (data not shown). These trials showed that A. vasorum and D. immitis share common epitopes 250 
inducing strong cross-reactions. For this reason, mAbs produced in this study were evaluated with E/S 251 
antigen of both adult A. vasorum and D. immitis, and several mAbs strongly reacting with D. immitis were 252 
excluded. Consequently, the use of the mAb Av 56/1/2 which did not react with D. immitis E/S antigen 253 
resulted in a highly specific sandwich-ELISA. Employing this species-specific mAb together with polyclonal 254 
rabbit antibodies directed against A. vasorum adult E/S antigen, the sandwich-ELISA was able to detect 255 
circulating antigens in the sera of patent naturally infected dogs with a high specificity. Therefore, the few 256 
positive reactions observed with sera of the control group or the group with proven other helminth infections 257 
(one of 23 D. immitis and one of 14 C. vulpis infected dogs) are unlikely to be caused by cross-reactions. 258 
Rather, occult A. vasorum infections or coinfections which could not be excluded, might the reasons for the 259 
seemingly false-positives. As a matter of fact, expertise is needed for larval differentiation from faecal 260 
samples, and a coinfection can be easily missed particularly if one larval type is dominating. 261 
The test sensitivity of the sandwich-ELISA increased over time of infection, reaching a sensitivity of 98.6% 262 
in experimentally inoculated dogs infected for 10 and more weeks. However, also during late prepatency 4-263 
5 weeks after inoculation, 20% of the dogs were seropositive, indicating that the employed mAb Av 56/1/2 264 
is directed against epitopes on parasitic stages that are present before larval excretion starts. The stage-265 
specificity of the monoclonal used will be analysed in detail in further studies. No evident correlation 266 
between worm burden detected at necropsy and OD values in ELISAs was observed. The reason why one 267 
experimentally infected dog with a high worm burden at necropsy at 55 dpi had only one seropositve 268 
sample (at day 35) remains enigmatic. Possibly, this dog would have become seropositive again later. The 269 
long term follow-up of two experimentally inoculated dogs showed that they remained seropositive up to a 270 
year. Serodiagnosis for circulating antigen is therefore a helpful tool even for dogs with chronic 271 
angiostrongylosis tending to excrete low numbers of larvae. 272 
Antigen detection was negative in experimentally inoculated dogs treated before patency, at 4 or 32 dpi, 273 
confirming the efficacy of the prophylactic use of imidacloprid/moxidectin (Advocate®) (Schnyder et al., 274 
2009). In four out of five dogs treated later (at 88-92 dpi), the therapeutic efficacy (Schnyder et al., 2010; 275 
Willesen et al., 2007) was verified by the absence of worms at necropsy, corresponding with decreasing 276 
ODs in the ELISA. One dog positive at necropsy but negative with the Baermann-Wetzel technique (data 277 
not shown) was still seropositive, as well as one dog necropsied 30 days after successful treatment. Thus, 278 
an effective treatment was followed by decreasing level of detected circulatory antigens, mainly until 279 
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seronegativity was reached. In contrast, in dogs that remain seropositive for more than 6 weeks after 280 
treatment, it can be assumed that the treatment was not successful and should therefore be repeated. Also 281 
post-treatment faecal examinations performed with the Baermann-Wetzel technique are not recommended 282 
to be done before 4 weeks after treatment, since larval excretion can be observed up to 3 weeks after 283 
successful treatment (Schnyder et al., 2010). 284 
Alternatively, the serological detection of antibodies directed against adult A. vasorum antigen could 285 
potentially represent a valid method for the diagnosis of canine angiostrongylosis. In early attempts for the 286 
serological detection of antibodies directed against adult A. vasorum antigen (Guilhon et al., 1971; Mishra 287 
and Benex, 1972), antibody detection started from 14 dpi, but potential cross-reactions against other 288 
nematodes such as C. vulpis or D. immitis were not analysed. Furthermore, it has to be considered that 289 
antibodies might persist over months after elimination of the worm burden.  290 
As shown by experimental infections, clinical signs and also echocardiographic changes in A. vasorum – 291 
infected animals may be subtle, even if the pathological changes of the lungs are considerable (Kranjc et 292 
al., 2010; Schnyder et al., 2010) and not completely reversible by anthelmintic treatment. In known endemic 293 
regions, prophylactic anthelmintic treatment (Conboy, 2004; Koch and Willesen, 2009; Schnyder et al., 294 
2009) or routine screening of dogs for A. vasorum infection (Verzberger-Epshtein et al., 2008) are 295 
recommended. The presented ELISA for the detection of circulating antigen represents a valid method for 296 
the reliable diagnosis of A. vasorum infection in dogs and for the control of the success of anthelmintic 297 
treatments. Moreover, the test can easily be used for mass-screening (i.e. with automated procedures) of 298 
dog populations, intended for a better understanding of epidemiological aspects of this probably 299 
underestimated disease. 300 
 301 
Acknowledgements 302 
We kindly thank the animal keepers, Armin Ruedemann and Esther Merz, for their great participation and 303 
support throughout the study, Lucia Kohler for intense laboratory tasks, the veterinarians Ruth Fiechter, 304 
Anna Fahrion, Sandra Staebler and Pete Ossent († 17.3.2010) for their very precious help during the trials, 305 
René Fischer and Angela Schucan for their contribution in the production of monoclonal antibodies. We 306 
also acknowledge Bayer Animal Health GmbH, Germany, for the financial contribution. 307 
 308 
References 309 
Al-Sabi, M.N., Deplazes, P., Webster, P., Willesen, J.L., Davidson, R.K., Kapel, C.M., 2010. PCR detection 310 
of Angiostrongylus vasorum in faecal samples of dogs and foxes. Parasitol. Res. 107, 135-140. 311 
Barutzki, D., Schaper, R., 2009. Natural infections of Angiostrongylus vasorum and Crenosoma vulpis in 312 
dogs in Germany (2007-2009). Parasitol. Res. 105 Suppl 1, 39-48. 313 
10 
 
Bolt, G., Monrad, J., Koch, J., Jensen, A.L., 1994. Canine angiostrongylosis: a review. Vet. Rec. 135, 447-314 
452. 315 
Chapman, P.S., Boag, A.K., Guitian, J., Boswood, A., 2004. Angiostrongylus vasorum infection in 23 dogs 316 
(1999-2002). J. Small Anim. Pract. 45, 435-440. 317 
Conboy, G., 2004. Natural infections of Crenosoma vulpis and Angiostrongylus vasorum in dogs in Atlantic 318 
Canada and their treatment with milbemycin oxime. Vet. Rec. 155, 16-18. 319 
Costa, J.O., Lima Dos Santos, W., Nascimento, E., 1996. Imunodiagnostico por ELISA da angiostrongilose 320 
canina experimental. Ary. Bras. Med. Zootec. 48, 491-495. 321 
Cury, M.C., Guimaraes, M.P., Lima, W.S., Vitor, R.W., 2002. Western blot analysis of the humoral response 322 
of dogs experimentally infected with Angiostrongylus vasorum (Baillet, 1866). Vet. Parasitol. 106, 323 
83-87. 324 
Cury, M.C., Lima, W.S., Vitor, R.W.A., 1996. Enzyme-Linked Immunosorbent Assay (ELISA) for the 325 
diagnosis of Angiostrongylus vasorum (Baillet, 1866) infection in dogs. Rev. Méd. Vét. 147, 525-326 
530. 327 
De Oliveira Vasconcelos, V., Wagner De Almeida, V.R., Dos Santos Lima, W., 2008. Identification of stage-328 
specific proteins of Angiostrongylus vasorum (Baillet, 1866) Kamensky. Parasitol. Res. 102, 389-329 
395. 330 
de StGroth, S.F., Scheidegger, D., 1980. Production of monoclonal antibodies: strategy and tactics. J. 331 
Immunol. Methods 35, 1-21. 332 
Deplazes, P., Smith, N.C., Arnold, P., Lutz, H., Eckert, J., 1995. Specific IgG1 and IgG2 antibody 333 
responses of dogs to Leishmania infantum and other parasites. Parasite Immunol. 17, 451-458. 334 
Eckert, J., Friedhoff, K.T., Zahner, H., Deplazes, P. 2008. Lehrbuch der Parasitologie für die Tiermedizin 335 
(Stuttgart, Enke Verlag). 336 
Ferdushy, T., Kapel, C.M., Webster, P., Al-Sabi, M.N., Gronvold, J., 2009. The occurrence of 337 
Angiostrongylus vasorum in terrestrial slugs from forests and parks in the Copenhagen area, 338 
Denmark. J. Helminthol., 83, 379–383. 339 
Guilhon, J., 1963. Recherches sur le cycle évolutif du Strongle des vaisseaux du chien. Bull. Acad. Vét. 36, 340 
431-442. 341 
Guilhon, J., Benex, J., Mishra, G.S., 1971. First attempts of immunological diagnosis of canine 342 
angiostrongylosis due to Angiostrongylus vasorum (in French). Bull. Soc. Pathol. Exotique et 343 
Filiales. 64, 220-228. 344 
Humm, K., Adamantos, S., 2010. Is evaluation of a faecal smear a useful technique in the diagnosis of 345 
canine pulmonary angiostrongylosis? J. Small Anim. Pract. 51, 200-203. 346 
11 
 
Jefferies, R., Morgan, E.R., Shaw, S.E., 2009. A SYBR green real-time PCR assay for the detection of the 347 
nematode Angiostrongylus vasorum in definitive and intermediate hosts. Vet. Parasitol. 166, 112-348 
118. 349 
Koch, J., Willesen, J.L., 2009. Canine pulmonary angiostrongylosis: An update. Vet. J. 179, 348-359. 350 
Kranjc, A., Schnyder, M., Dennler, M., Fahrion, A., Makara, M., Ossent, P., Morgan, J., Deplazes, P., 351 
Glaus, T.M., 2010. Pulmonary artery thrombosis in experimental Angiostrongylus vasorum infection 352 
does not result in pulmonary hypertension and echocardiographic right ventricular changes. J. Vet. 353 
Int. Med. 24, 855-862. 354 
McGarry, J.W., Morgan, E.R., 2009. Identification of first-stage larvae of metastrongyles from dogs. Vet. 355 
Rec. 165, 258-261. 356 
Mishra, G.G., Benex, J., 1972. Immunological specificity on Angiostrongylus cantonensis and A. vasorum 357 
(Nematoda). Indian J. Anim. Sci. 42, 614-667. 358 
Schnyder, M., Fahrion, A., Ossent, P., Kohler, L., Webster, P., Heine, J., Deplazes, P., 2009. Larvicidal 359 
effect of imidacloprid/moxidectin spot-on solution in dogs experimentally inoculated with 360 
Angiostrongylus vasorum. Vet. Parasitol. 166, 326-332. 361 
Schnyder, M., Fahrion, A., Riond, B., Ossent, P., Webster, P., Kranjc, A., Glaus, T., Deplazes, P., 2010. 362 
Clinical, laboratory and pathological findings in dogs experimentally infected with Angiostrongylus 363 
vasorum. Parasitol. Res., DOI 10.1007/s00436-010-2021-9. 364 
Staebler, S., Ochs, H., Steffen, F., Naegeli, F., Borel, N., Sieber-Ruckstuhl, N., Deplazes, P., 2005. 365 
Autochthonous infections with Angiostrongylus vasorum in dogs in Switzerland and Germany (in 366 
German). Schweiz. Arch. Tierheilkd. 147, 121-127. 367 
Taubert, A., Pantchev, N., Vrhovec, M.G., Bauer, C., Hermosilla, C., 2008. Lungworm infections 368 
(Angiostrongylus vasorum, Crenosoma vulpis, Aelurostrongylus abstrusus) in dogs and cats in 369 
Germany and Denmark in 2003-2007. Vet. Parasitol. 159, 175-180. 370 
Traversa, D., Guglielmini, C., 2008. Feline aelurostrongylosis and canine angiostrongylosis: a challenging 371 
diagnosis for two emerging verminous pneumonia infections. Vet. Parasitol. 157, 163-174. 372 
Verzberger-Epshtein, I., Markham, R.J., Sheppard, J.A., Stryhn, H., Whitney, H., Conboy, G.A., 2008. 373 
Serologic detection of Angiostrongylus vasorum infection in dogs. Vet. Parasitol. 151, 53-60. 374 
Webster, P., Monrad, J., Kapel, C.M.O., Thamsborg, S.M., 2007. Infection biology of Angiostrongylus 375 
vasorum in foxes (Vulpes vulpes) with emphasis on the impact of host age, infection dose and 376 
exposure. In:  The 21st International Conference of the World Association for the Advancement of 377 
Veterinary Parasitology, Gent, Belgium, p. 166. 378 
12 
 
Willesen, J.L., Kristensen, A.T., Jensen, A.L., Heine, J., Koch, J., 2007. Efficacy and safety of 379 
imidacloprid/moxidectin spot-on solution and fenbendazole in the treatment of dogs naturally 380 
infected with Angiostrongylus vasorum (Baillet, 1866). Vet. Parasitol. 147, 258-264. 381 
 382 
383 
13 
 
Table 1: Detection of circulating antigen of Angiostrongylus vasorum in serum by ELISA in dogs 384 
experimentally inoculated with Angiostrongylus vasorum (CI: Confidence Interval).  385 
Weeks post inoculation No. dogsa positive / tested sera (%; 95% CI) 
 
-1 22 0/22 (0; 0.0-12.7) 
1-3 22 0/52b (0; 0.0-5.6) 
4-5 22 6/30c (20.0; 7.7-38.6) 
6-7 22 10/30d (33.3; 17.3-52.8) 
8-9 22 19/30e (63.3; 43.9-80.1) 
10-51 14 70/71f (98.6; 92.4-100) 
 386 
a The study included 17 untreated dogs necropsied at different time points and 5 dogs with anthelmintic 387 
treatment at 88-92 days post inoculation (dpi). 388 
b blood sampling frequency: all dogs on 7 and 21 dpi,  additionally 8 dogs on 13 dpi. 389 
c blood sampling frequency: all dogs on 35 dpi, additionally 8 dogs on 27 dpi. 390 
d 
 blood sampling frequency: all dogs on 49 dpi, additionally 8 dogs on 41 dpi. 391 
e blood sampling frequency: 16 dogs on 55 dpi, 14 dogs on 63 dpi. 392 
f blood sampling frequency: 14 dogs every week or every second week up to 92 dpi; afterwards 3 dogs 393 
every second week up to 188 dpi, followed by bleeding on 230 (3 dogs), 286 (2 dogs), 314, 342, 394 
356 (one dog) dpi. 395 
396 
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 397 
Figure 1:  398 
Detection of circulating Angiostrongylus vasorum antigen in sera of dogs excreting Angiostrongylus 399 
vasorum or Crenosoma vulpis larvae, positive for circulating Dirofilaria immitis antigen in serum and/or 400 
microfilariae, or experimentally infected with Ancylostoma caninum or Toxocara canis. The cut-off value for 401 
the discrimination between seropositive and seronegative samples was determined by the mean plus 3 402 
standard deviation of the OD values of 30 control sera. 403 
 404 
Figure 2: 405 
Serological follow up of circulating Angiostrongylus vasorum antigen in sera of 15 dogs experimentally 406 
infected with Angiostrongylus vasorum (the number represents the worm burden of adult stages at 407 
necropsy; cut-off determination see Fig. 1). Bleeding intervals: 1-2 weeks. 408 
 409 
Figure 3: 410 
Serological long-term follow up of circulating Angiostrongylus vasorum serum antigen in 2 dogs 411 
experimentally infected with Angiostrongylus vasorum (the number represents the worm burden of adult 412 
stages at necropsy; cut-off determination see Fig. 1). Bleeding intervals: 1-6 weeks. 413 
 414 
Figure 4: 415 
Serological follow up of circulating Angiostrongylus vasorum antigen in sera of 5 dogs experimentally 416 
inoculated with Angiostrongylus vasorum and treated with imidacloprid/moxidectin (Advocate®) at 88 or 92 417 
(↓) days post inoculation (the number represents the worm burden of adult stages at necropsy; cut-off 418 
determination see Fig. 1). Bleeding intervals: 1-2 weeks. 419 
420 
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